Treatment.com AI Balance Sheet Health

Financial Health criteria checks 0/6

Treatment.com AI has a total shareholder equity of CA$-665.2K and total debt of CA$609.2K, which brings its debt-to-equity ratio to -91.6%. Its total assets and total liabilities are CA$1.0M and CA$1.7M respectively.

Key information

-91.6%

Debt to equity ratio

CA$609.17k

Debt

Interest coverage ration/a
CashCA$897.39k
Equity-CA$665.18k
Total liabilitiesCA$1.71m
Total assetsCA$1.04m

Recent financial health updates

Recent updates

We Think Treatment.Com International (CSE:TRUE) Needs To Drive Business Growth Carefully

Jan 17
We Think Treatment.Com International (CSE:TRUE) Needs To Drive Business Growth Carefully

Is Treatment.Com International (CSE:TRUE) In A Good Position To Deliver On Growth Plans?

Oct 01
Is Treatment.Com International (CSE:TRUE) In A Good Position To Deliver On Growth Plans?

Financial Position Analysis

Short Term Liabilities: TRUE has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: TRUE has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: TRUE has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: TRUE's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if TRUE has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if TRUE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:58
End of Day Share Price 2024/12/20 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Treatment.com AI Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution